Allergan signs $1.5 billion deal with Molecular Partners
August 22, 2012Research and Development, Sales and Marketing Allergan, Molecular Partners, eye diseases
Allergan has signed a deal potentially worth $1.5 billion with Molecular Partners to develop new drugs for certain eye diseases. …
UK government pushes through formulary changes
August 22, 2012Sales and Marketing CCGs, NHS, NICE, PCTs, UK, lottery, prescribing
The government has written to NHS prescribing leads telling them they must start to incorporate NICE guidance into their formularies. …
UK doctors not going digital for product information
August 22, 2012Medical Communications GPs, UK, digital, doctorsnet
A new survey has revealed that the majority of doctors in the UK are not looking online for information about …
Lundbeck makes two senior appointments
August 22, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andreas Eggert, Klaus Abel, Lundbeck
Lundbeck has appointed Andreas Eggert (pictured) as senior vice president for global product strategy, and Klaus Abel as vice president …
Another NICE no for Avastin in breast cancer
August 22, 2012Sales and Marketing NICE, avastin, breast cancer, rejection
Roche’s Avastin has been rejected once again for use in breast cancer patients. NICE has now issued final guidance saying …
Pfizer’s arthritis drug delayed by FDA
August 21, 2012Research and Development, Sales and Marketing FDA, Pfizer, tofacitinib
Pfizer says its new rheumatoid arthritis drug tofacitinib has been delayed by the FDA. Tofacitinib, an oral Janus kinase (JAK) …
Charity launches ‘Diabetes App Challenge’
August 21, 2012Medical Communications apps, diabetes, digital
Diabetes UK has launched its Diabetes App Challenge for younger insulin dependent patients. The Diabetes App Challenge wants people with …
NICE bows to industry pressure
August 21, 2012Sales and Marketing ABPI, NICE, QALY, VBP
NICE has bowed to industry pressure and will allow independent advisors to sit on its appeals board. An appeal can …
INC Research promotes Jamie Macdonald to chief executive
August 21, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing INC Research, Jamie Macdonald
Clinical research organisation INC Research has announced chief operating officer Jamie Macdonald will become the firm’s next president and chief …
ABPI slams NICE International
August 20, 2012Sales and Marketing ABPI, NICE, NICE International, Romania, hta
The ABPI has expressed concerns over the remit of NICE International and its affect on global markets. NICE International is …
Pharma manufacturing news in brief
August 20, 2012Manufacturing and Production, Sales and Marketing Cambrex, GSK, Laureate, Morphotek
GlaxoSmithKline says it has shut down one of its two manufacturing facilities in India after offering all workers there early …
Roche winning on Perjeta supply, but running short of Boniva
August 20, 2012Manufacturing and Production, Sales and Marketing Boniva, Perjeta, Roche, breast cancer
Roche is getting production for its new breast cancer drug Perjeta back on track after some initial teething troubles, but …
Hospira hit by yet another product recall
August 20, 2012Manufacturing and Production, Sales and Marketing Carpuject, Hospira, overdose, recall
Generic pharma company Hospira has been forced to recall another product as it works to rectify quality issues at three …
Claris LifeSciences gets clean bill of health from FDA
August 20, 2012Manufacturing and Production, Sales and Marketing Claris, FDA, Pfizer, sterile
Indian drugmaker Claris LifeSciences seems to have set its house in order after manufacturing issues led the FDA to impose …
GSK severe asthma drug progresses to Phase III
August 20, 2012Research and Development, Sales and Marketing Advair, GSK, Phase II, asthma, phase III
GlaxoSmithKline’s severe asthma drug mepolizumab has impressed in a mid-stage study, meaning it can now progress into Phase III testing. …
Generic Actos gains FDA approval
August 20, 2012Sales and Marketing Actos, Mylan, Ranbaxy, Takeda, diabetes, generic
Takeda’s big-selling diabetes pill Actos will have its US sales decimated after the FDA approves three copycat versions of the …
Euro RSCG Life UK expands account services team
August 17, 2012Medical Communications Euro RSCG Life UK, Havas, Lucretia King
Euro RSCG Life UK, a leading healthcare communications network, is pleased to announce the appointment of Lucretia King as client …
Reynolds-MacKenzie appoints new leadership team
August 17, 2012Medical Communications Reynolds-Mackenzie
Reynolds-MacKenzie has made two new senior hires and an internal promotion to help drive its UK and international operations. The …
IPA Best of Health 2012 Awards highlights
August 17, 2012Medical Communications Best of Health, IPA, IPA Best of Health Awards, McCann Torre Lazur, advertising
McCann Torre Lazur and The Cement Bloc were awarded the prestigious ‘Best of Show’ awards at the 2012 IPA Best …
Xgeva gains NICE recommendation for bone metastasis
August 17, 2012Sales and Marketing Amgen, NICE, Xgeva, bone metastatis
NICE is continuing to recommend Amgen’s Xgeva for certain groups of cancer patients whose disease has spread to their bones. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
